EU medicines regulator says benefits of J&J vaccine outweigh risks as it reviews rare blood clots
April 14, 2021 at 09:59 AM EDT
Europe's medicines regulator on Wednesday said it still believes the benefits of Johnson & Johnson's Covid-19 vaccine outweigh the risks of side effects.
